4[4]Jordan VC.Tamoxifen:a most unlikely pioneering medicine[J].Nat Rev Drug Discov,2003,2(3):205～213. 被引量：1
5[5]HOWell A,Osborre CK,Morris C,et al.ICI 182,780(Faslodex):developent of a novel,"Pure"antiestrogen[J].Cancer,2000,89(4):817～825. 被引量：1
6[6]Piccart M,Parker LM,Pritchard KI.Oestrogen receptor downregulation :an opportunity for extending the window of endocrine therapy in advanced breas t cancer[J].Ann Oncol,2003,14(7):1017～1025. 被引量：1
8[9]Visvanathan K,Davidson NE.Aromatase inhibitors as adjuvant therapy in breast cancer[J].Oncology,2003,17(3):335～342. 被引量：1
9[10]Lake DE,Hudis C.Aromatase inhibitors in breast cancer:an update[ J].Cancer Control,2002,9(6):490～498. 被引量：1
10[11]Kaufmann A Zoladex TM(Goserelin)vs CMF as adjuvant therapy in pre/perimenopausal,node-positive,early breast cancer;preliminary effica cyresults from the ZEBRA study[J].The Breast,2001,10(suppl 1):s30. 被引量：1
4Tremblay A, Tremblay G B, Labile F, et al. Ligand- independent recruitment of SRC1 to estrogen receptor beta through phosphorylation of activation function A F- 1 [ J ].Mol Cell, 2001, 3: 513. 被引量：1
5Gee J M, Robertson J F, Ellis I O, et al. Phosphorylation of ERK 1/2 mitogen-aetivated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer[J]. Int J Cancer, 2001, 95(4) : 247. 被引量：1
6Kuiper G G, Enmark, E, Pelto-Huikko, et al. Cloning of a novel receptor expressed in rat prostate and ovary[J]. Proe Nail Acad Sci USA, 1996, 93: 5925. 被引量：1
7Mosselman S, Polman J, Dijkema, R. ER: identification and characterization of a novel human estrogen receptor[J ].FEBS Lett, 1996, 392: 49. 被引量：1
8Tremblay, G B, Tremblay, A, Copeland, N G, et al.Cloning, chromosomal localization, and finctional analysis of the murine estrogen receptor[J ]. Mol Endoerinol, 1997,11 : 353. 被引量：1
9Gazet J C, Coombes R C, Ford H T, et al. Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer[J]. Br J Cancer, 1996, 73: 758. 被引量：1
10Dixon J M, Love CDB, Tucker S, et al. Letrozole as primary mediesl therapy for locally advanced and large operable breast cancer[J]. Proc ASCO. 1998. 17: 104. 被引量：1
